ID ...... Создание производства лекарственных препаратов

• Дата добавления

  18.04.2025

• Последнее обновление

  14.05.2025

• Стадия

  

  Введен в эксплуатацию

• Тип работ

  Новое строительство

• Местоположение

  ·········· ················ ················ ···· ············ ·············· ······

• Краткое описание

  Компания-инвестор планирует реализовать проект по созданию производства лекарственных препаратов на территории Узбекистана.

• Полное описание

  ······ ········ ·············· ········ ·········· ·············· ·············· ········ ········ ···· ······ ············ ········ ········ ···· ·········· ············ ············ ·········· ·············· ················ ············ ········ ················ ···· ·········· ···· ····

• Результаты интервью

  Инвестор

  ···· ·················· ···· ····.····.········ ········ ···· ············ ················ ·················· ·········· ·················· ······ ············ ············ ·· ··························

• Объем инвестиций

  ········ ··············

• Сроки проекта

  2022 — II квартал, 2025 год

• Вид собственности

  Частный

• Отрасль

  Фармацевтическая промышленность

• Подотрасль

  Лекарственные препараты

• Производственная мощность

  ················ ····

• Готовая продукция

  ················ ·········· ·············· ················ ······ ·········· ·············· ········ ···· ··············

• Топ-25 проектов страны

  1. ID ···· ·············· ·············· ·············· (Приостановлен на стадии предпроектные проработки) (Узбекистан) — ········· трлн руб

  2. ID ···· ···· ·········· ········ ···· ·········· ········ ······ ·········· (Строительство (нулевой цикл)) (Узбекистан) — ········· млрд руб

  3. ID ······ ······ ······ ················ ···· (Строительство (нулевой цикл)) (Узбекистан) — ········· млрд руб

  4. ID ············ ·············· ······ ·············· (Отменен) (Узбекистан) — ········· млрд руб

  5. ID ·········· ···· ···· (Строительство (нулевой цикл)) (Узбекистан) — ········· млрд руб

  
  Анализ страны